Amikacin concentrations in serum and blister fluid in healthy volunteers and in patients with renal impairment
- PMID: 6671925
- DOI: 10.1093/jac/12.5.481
Amikacin concentrations in serum and blister fluid in healthy volunteers and in patients with renal impairment
Abstract
Following iv administration of 0.5 g of amikacin, the concentrations of the antibiotic were determined in serum and blister fluid of nine healthy volunteers and ten patients with renal impairment. In the former, the maximum concentrations of amikacin in blister fluid was 11.85 +/- 4.6 mg/l. The half-life in blister fluid was 2.39 +/- 1.10 h, slightly greater than that of serum (1.73 +/- 0.24 h). The concentrations of the antibiotic in serum and blister fluid are modified significantly in patients with renal impairment. The half-life values in both fluids increase similarly, parallel to the reduction in renal function. The penetration of amikacin into blister fluid in these patients increases progressively and a linear relationship is established between the maximum concentration reached and creatinine clearance. A linear relationship has also been established between the concentration of the antibiotic in serum and blister fluid.
Similar articles
-
Distribution kinetics of netilmicin in human blister fluid: effect of renal impairment.Biopharm Drug Dispos. 1991 Mar;12(2):149-62. doi: 10.1002/bdd.2510120208. Biopharm Drug Dispos. 1991. PMID: 2031996
-
Pharmacokinetics of amikacin in children with normal and impaired renal function.Kidney Int. 1981 Jul;20(1):115-21. doi: 10.1038/ki.1981.112. Kidney Int. 1981. PMID: 7300106
-
Disposition kinetics of amikacin in patients with renal impairment after intramuscular administration.Int J Clin Pharmacol Ther Toxicol. 1982 Jun;20(6):271-5. Int J Clin Pharmacol Ther Toxicol. 1982. PMID: 7107075
-
Antimicrobial spectrum, pharmacology, adverse effects, and therapeutic use of amikacin sulfate.Am J Hosp Pharm. 1981 Jul;38(7):981-9. Am J Hosp Pharm. 1981. PMID: 7020413 Review.
-
Amikacin.Ann Intern Med. 1981 Sep;95(3):328-32. doi: 10.7326/0003-4819-95-3-328. Ann Intern Med. 1981. PMID: 7023310 Review. No abstract available.
Cited by
-
Antibiotics in Necrotizing Soft Tissue Infections.Antibiotics (Basel). 2021 Sep 13;10(9):1104. doi: 10.3390/antibiotics10091104. Antibiotics (Basel). 2021. PMID: 34572686 Free PMC article. Review.
-
Clinical pharmacokinetics of antibiotics in patients with impaired renal function.Clin Pharmacokinet. 1992 Mar;22(3):169-210. doi: 10.2165/00003088-199222030-00002. Clin Pharmacokinet. 1992. PMID: 1559311 Review.
-
Failure to predict amikacin elimination in critically ill patients with cancer based on the estimated glomerular filtration rate: applying PBPK approach in a therapeutic drug monitoring study.Eur J Clin Pharmacol. 2023 Jul;79(7):1003-1012. doi: 10.1007/s00228-023-03516-1. Epub 2023 May 31. Eur J Clin Pharmacol. 2023. PMID: 37256410
-
Prediction of tissue exposures of polymyxin-B, amikacin and sulbactam using physiologically-based pharmacokinetic modeling.Front Microbiol. 2024 Oct 7;15:1435906. doi: 10.3389/fmicb.2024.1435906. eCollection 2024. Front Microbiol. 2024. PMID: 39435440 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical